BreathCare PAP III (YH-390N)
Suzhou Yuyue Medical Technology Co., Ltd. · Decision date Oct 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-23 for K260251, a traditional 510(k) submitted 01/27/2026 by Suzhou Yuyue Medical Technology Co., Ltd. of Suzhou, CN. The device is BreathCare PAP III (YH-390N), listed under classification name Ventilator, Non-Continuous (Respirator), regulation 868.5905, product code BZD, with anesthesiology as the regulation medical specialty and review panel. SESE indicates clearance to market, not PMA approval.
The record shows no third-party review, no combination product designation, and no authorized predetermined change control plan. The listed correspondent is the same firm, with Fang Zhang as contact for both applicant and correspondent. The source does not describe device components, the technological characteristics compared with a predicate, or the basis for the equivalence finding; those details would sit in the underlying 510(k) review documents, which are not included here. No clinical or performance conclusions are drawn.
The public page was last updated 11/02/2026. Whether the device is currently marketed, and any labeling or indication specifics, remain unknown from this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Oct 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260251
- Regulatory pathway
- 510(k) premarket notification
- Product code
- BZD
- Decision code
- SESE
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventilator, Non-Continuous (Respirator).
- Product code
- BZD
- FDA device class
- 2
FDA decision timeline
K260251 received
Application receipt date recorded by FDA.
K260251 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code BZD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Altis Full Face MaskK261262 | Respironics, Inc. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Suzhou Yuyue Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suzhou
Sources and methodology
- Original FDA record: K260251
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records